Ping Xie - Feinberg School of Medicine, Northwestern University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

CD8+ T Cells Sustain Antitumor Response by Mediating Crosstalk Between Adenosine A2A Receptor and Glutathione/gpx4

Siqi Chen,Jie Fan,Ping Xie,Jihae Ahn, Michelle Fernandez,Leah K. Billingham,Jason Miska,Jennifer D. Wu,Derek A. Wainwright,Deyu Fang,Jeffrey A. Sosman,Yong Wan,Yi Zhang,Navdeep S. Chandel,Bin Zhang

JOURNAL OF CLINICAL INVESTIGATIONno. 8 (2024)

引用0浏览0WOS引用

Abstract 7047: Comparative Analysis of Transcriptomic and Immunological Profiles in Treatment-Naïve Black and Non-Hispanic White Women with High-Grade Serous Ovarian Cancer

Hao Huang, Russel Keathley, Kim,Horacio Cardenas,Ping Xie,Jianjun Wei,Guangyuan Zhao,Emma L. Barber,Ernst Lengyel,Kenneth P. Nephew, Victoria Bae-Jump,Bin Zhang,Daniela Matei

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Development of Effective Immunotherapy for Triple Negative Breast Cancer by WEE1 Kinase Inhibition

Mi Ran Choi,Ping Xie, Hui Tang, Jie Fan,Ji Hae Ahn, Rachel Orpano,Bin Zhang

The Journal of Immunologyno. 1_Supplement (2023): 230.17-230.17

引用0浏览0引用

Reprogramming of Tumor-Induced Emergency Granulopoiesis Overcomes Immune Checkpoint Therapy Resistance

Hui Tang,Ping Xie,Ji Hae Ahn,Mi Ran Choi,Jie Fan, Rachel Orpano,Bin Zhang

JOURNAL OF IMMUNOLOGYno. 1 (2023)

引用0浏览0引用

A Phase Ib Study to Evaluate the Safety and Efficacy of Nivolumab in Combination with RCHOP in High-Risk DLBCL

Oluwatobi Odetola,Shuo Ma,Jane N. Winter,Barbara Pro,Ishan Roy,Ping Xie,Bin Zhang, George Koulogeorgas,Xinlei Mi,Robert Bayer, Robert Eisner,Valerie Nelson, Habib Shaikh,Dean Tsarwhas, Faisal Saghir,Parameswaran Venugopal,Leo I. Gordon,Reem Karmali

BLOOD (2023)

引用0浏览0引用

Abstract 6068: Methylomic, Transcriptomic and Immune Profiles of High Grade Serous Ovarian Cancer among Black and Non-Hispanic White Women

Hao Huang,Russell Keathley,Ping Xie,JianJun Wei,Ernst Lengyel,Bin Zhang,Daniela Matei

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Metabolic Reprogramming of Antitumor CD8+ T Cells by Modulation of GSH-Gpx4 Axis

Siqi Chen,Jie Fan,Ping Xie,Jihae Ahn, Michelle Fernandez,Navdeep Chandel,Bin Zhang

JOURNAL OF IMMUNOLOGYno. 1 (2022)

引用0浏览0引用

Immune Characterization in Platinum Resistant Ovarian Cancer Patients Treated with Pembrolizumab and Guadecitabine

Ping Xie,Siqi Chen,Mathew Cowan,Hao Huang,Horacio Cardenas,Masha Kocherginsky,Daniela Matei,Bin Zhang

JOURNAL OF IMMUNOLOGYno. 1 (2022)

引用0浏览0引用

Treatment with Pembrolizumab in Combination with the Oncolytic Virus Pelareorep Promotes Anti-Tumor Immunity in Patients with Advanced Pancreatic Adenocarcinoma

Devalingam Mahalingam,Siqi Chen,Ping Xie,Aparna Kalyan,Sheetal Mehta Kircher,Masha Kocherginsky,Jiahui Xu,Victoria Maurer,Pedro Antonio Hermida de Viveiros,Elena Vagia,Grey A. Wilkinson,Matthew C. Coffey,Mary Frances Mulcahy,Al Bowen Benson,Bin Zhang

Journal of clinical oncologyno. 15_suppl (2021): 4144-4144

引用3浏览0引用

Immune Markers of Response to Pembrolizumab and Guadecitabine in Platinum Resistant Ovarian Cancer Utilizing Multiplex Immunohistochemistry (Mihc)

Matthew Cowan,Ping Xie,Siqi Chen,Horacio Cardenas,Masha Kocherginsky,Bin Zhang,Daniela Matei

Gynecologic Oncology（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn